Gara Jalqabaatti › Dhibee Seli Sikiilii › Distaarikii Koloombiyaa › Washington
Qorannoo klinikaalii Dhibee Seli Sikiilii Washington, DC keessatti
Qorannoo 20 Dhibee Seli Sikiilii f Washington fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Blood Sampling for Research Related to Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Namoota walitti qabaa jiraSadarkaa 3
- Childrens National Hospital, Washington D.C.
Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 3
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
Namoota walitti qabaa jiraSadarkaa 1
- National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · Miili 7 fagaatti
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Namoota walitti qabaa jiraSadarkaa 1/2
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 1
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Namoota walitti qabaa jiraQorannoo ilaalaa
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Namoota walitti qabaa jiraSadarkaa 2
- Center for Cancer and Blood Disorders, Bethesda · Miili 7 fagaatti
Cooperative Assessment of Late Effects for SCD Curative Therapies
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's National Medical Center, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · Miili 7 fagaatti
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's National Hospital (MRD-HCT), Washington D.C.
Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 2
- Children's National Hospital, Washington D.C.
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Namoota walitti qabaa jiraSadarkaa 2
- Children's National Health System, Washington D.C.
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
Namoota walitti qabaa jiraSadarkaa 2
- Children's National Hospital, Washington D.C.
Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
Namoota walitti qabaa jira
- Children's National Hospital, Washington D.C.
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Namoota walitti qabaa jira
- Children's National Hospital, Washington D.C.
Qorannoo Dhibee Seli Sikiilii magaalota biroo keessatti
- Atlanta, GAQorannoo 22
- Chicago, ILQorannoo 18
- Memphis, TNQorannoo 18
- Philadelphia, PAQorannoo 15
- Birmingham, ALQorannoo 14
- New York City, NYQorannoo 13
- St. Louis, MOQorannoo 12
- Boston, MAQorannoo 10
- Durham, NCQorannoo 10
- Houston, TXQorannoo 10
- Cincinnati, OHQorannoo 10
- Greenville, NCQorannoo 9
Qorannoo biroo Washington keessatti
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 55
- Saree OljooQorannoo 46
- Kansara MetastatikiiQorannoo 43
- Dhibee QaraQorannoo 41
- Kansarii ProstateQorannoo 38
- ObesityQorannoo 33
- Kansarii ColorectalQorannoo 29
- Dhibee Onneessaa fi DhiigaQorannoo 28
- Dukkana BladderQorannoo 26
- Leukemia Myeloidii HamaaQorannoo 24
- Kansarii OvariiQorannoo 23
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.